OBJECTIVE: Acute respiratory failure is a significant complication of severe pneumococcal pneumonia. In a mouse model, we observed early-onset lung microvascular leakage after pulmonary infection with Streptococcus pneumoniae, and we hypothesized that the important virulence factor pneumolysin may be the direct causative agent. DESIGN: Controlled, in vivo, ex vivo, and in vitro laboratory study. SETTING: Laboratory. SUBJECTS: Female mice, 8-12 wks old. INTERVENTIONS: Ventilated and blood-free perfused murine lungs were challenged with recombinant pneumolysin via the airways as well as via the vascular bed. In addition, we analyzed the impact of pneumolysin on electrical cell impedance and hydraulic conductivity of human umbilical vein endothelial cell (HUVEC) and alveolar epithelial cell (A549) monolayers. MEASUREMENTS AND MAIN RESULTS: Aerosolized pneumolysin dose-dependently increased capillary permeability with formation of severe lung edema but did not affect pulmonary vascular resistance. Intravascular pneumolysin caused an impressive dose-dependent increase in pulmonary vascular resistance and in lung microvascular permeability. By immunohistochemistry, pneumolysin was detected mainly in endothelial cells of pulmonary arterial vessels, which concomitantly displayed strong vasoconstriction. Moreover, pneumolysin increased permeability of HUVEC and A549 monolayers. Interestingly, immunofluorescence of endothelial cell monolayers exposed to pneumolysin showed gap formation and moderate stress fiber generation. CONCLUSIONS: Pneumolysin may play a central role for early-onset acute lung injury due to severe pneumococcal pneumonia by causing impairment of pulmonary microvascular barrier function and severe pulmonary hypertension.
OBJECTIVE: Acute respiratory failure is a significant complication of severe pneumococcal pneumonia. In a mouse model, we observed early-onset lung microvascular leakage after pulmonary infection with Streptococcus pneumoniae, and we hypothesized that the important virulence factor pneumolysin may be the direct causative agent. DESIGN: Controlled, in vivo, ex vivo, and in vitro laboratory study. SETTING: Laboratory. SUBJECTS: Female mice, 8-12 wks old. INTERVENTIONS: Ventilated and blood-free perfused murine lungs were challenged with recombinant pneumolysin via the airways as well as via the vascular bed. In addition, we analyzed the impact of pneumolysin on electrical cell impedance and hydraulic conductivity of human umbilical vein endothelial cell (HUVEC) and alveolar epithelial cell (A549) monolayers. MEASUREMENTS AND MAIN RESULTS: Aerosolized pneumolysin dose-dependently increased capillary permeability with formation of severe lung edema but did not affect pulmonary vascular resistance. Intravascular pneumolysin caused an impressive dose-dependent increase in pulmonary vascular resistance and in lung microvascular permeability. By immunohistochemistry, pneumolysin was detected mainly in endothelial cells of pulmonary arterial vessels, which concomitantly displayed strong vasoconstriction. Moreover, pneumolysin increased permeability of HUVEC and A549 monolayers. Interestingly, immunofluorescence of endothelial cell monolayers exposed to pneumolysin showed gap formation and moderate stress fiber generation. CONCLUSIONS: Pneumolysin may play a central role for early-onset acute lung injury due to severe pneumococcal pneumonia by causing impairment of pulmonary microvascular barrier function and severe pulmonary hypertension.
Authors: Rudolf Lucas; Supriya Sridhar; Ferenc G Rick; Boris Gorshkov; Nagavedi S Umapathy; Guang Yang; Aluya Oseghale; Alexander D Verin; Trinad Chakraborty; Michael A Matthay; Evgeny A Zemskov; Richard White; Norman L Block; Andrew V Schally Journal: Proc Natl Acad Sci U S A Date: 2012-01-23 Impact factor: 11.205
Authors: István Czikora; Abdel Alli; Hui-Fang Bao; David Kaftan; Supriya Sridhar; Hans-Jürgen Apell; Boris Gorshkov; Richard White; Astrid Zimmermann; Albrecht Wendel; Meike Pauly-Evers; Jürg Hamacher; Irène Garcia-Gabay; Bernhard Fischer; Alexander Verin; Zsolt Bagi; Jean Francois Pittet; Waheed Shabbir; Rosa Lemmens-Gruber; Trinad Chakraborty; Ahmed Lazrak; Michael A Matthay; Douglas C Eaton; Rudolf Lucas Journal: Am J Respir Crit Care Med Date: 2014-09-01 Impact factor: 21.405
Authors: Sharavathi Guddehalli Parameswarappa; Katrin Reppe; Andreas Geissner; Petra Ménová; Subramanian Govindan; Adam D J Calow; Annette Wahlbrink; Markus W Weishaupt; Bopanna Ponnappa Monnanda; Roland Lawrence Bell; Liise-Anne Pirofski; Norbert Suttorp; Leif Erik Sander; Martin Witzenrath; Claney Lebev Pereira; Chakkumkal Anish; Peter H Seeberger Journal: Cell Chem Biol Date: 2016-11-03 Impact factor: 8.116
Authors: Danielle Salha; Jason Szeto; Lisa Myers; Carol Claus; Anthony Sheung; Mei Tang; Belma Ljutic; David Hanwell; Karen Ogilvie; Marin Ming; Benjamin Messham; Germie van den Dobbelsteen; Robert Hopfer; Martina M Ochs; Scott Gallichan Journal: Infect Immun Date: 2012-04-02 Impact factor: 3.441
Authors: Jan Gert Nel; Chrisna Durandt; Timothy J Mitchell; Charles Feldman; Ronald Anderson; Gregory R Tintinger Journal: Lung Date: 2016-05-18 Impact factor: 2.584